Compare SNX & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SNX | HOLX |
|---|---|---|
| Founded | 1980 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Medical Electronics |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.2B | 16.9B |
| IPO Year | 2003 | 1995 |
| Metric | SNX | HOLX |
|---|---|---|
| Price | $225.78 | $76.02 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 13 |
| Target Price | ★ $198.70 | $77.89 |
| AVG Volume (30 Days) | 1.0M | ★ 20.9M |
| Earning Date | 03-31-2026 | 04-30-2026 |
| Dividend Yield | ★ 0.84% | N/A |
| EPS Growth | ★ 25.16 | N/A |
| EPS | ★ 4.04 | 0.79 |
| Revenue | ★ $20,053,764,000.00 | $4,100,500,000.00 |
| Revenue This Year | $9.11 | $4.74 |
| Revenue Next Year | $5.69 | $5.03 |
| P/E Ratio | ★ $56.02 | $96.23 |
| Revenue Growth | ★ 17.65 | 1.74 |
| 52 Week Low | $108.19 | $51.90 |
| 52 Week High | $227.61 | $76.07 |
| Indicator | SNX | HOLX |
|---|---|---|
| Relative Strength Index (RSI) | 82.66 | 69.09 |
| Support Level | $146.57 | $75.10 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 5.73 | 0.19 |
| MACD | 1.36 | 0.03 |
| Stochastic Oscillator | 89.37 | 95.19 |
TD Synnex Corp is a distributor and solutions aggregator for the IT ecosystem. The company aggregates and distributes IT hardware, software, and systems including personal computing devices and peripherals, mobile phones and accessories, printers, server and data center infrastructure, hybrid cloud, security, networking, communications and storage solutions, and system components. Its geographical segments include the Americas, Europe, and APJ.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.